~ FDA Breakthrough Therapy designation received for PF614-MPAR ~ ~ PF614-MPAR second clinical trial initiated ~ ~ Lead clinical candidate identified for OUD program ~ ~ PF614 Phase 3 trial poised to ...

We tested a dozen smartwatches for months, over thousands of miles and hundreds of workouts, to find the best for tracking ...

While all generations have witnessed a fair share of churn, the exit of Generation Z employees has touched a raw nerve.

Ascensia is a member of PHC Group and was established in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings Corporation. Ascensia products are sold in more than 100 countries.

On December 17, 2024, amid a flurry of activity by the Consumer Financial Protection Bureau (CFPB), the agency released an Issue Spotlight ...

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent ...

Audrey Mourguiart is Head of Social Innovation at Amadeus and Project Lead of Travel4Impact, an initiative run by Amadeus and ...

The Mira Technology Park in the UK's midlands houses major automotive R&D operations, benefiting from the power of industrial ...

REI is shutting down its classes, tours, and events business, collectively known as Experiences. The outdoor retailer ...

Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal ...

The Greater Toronto Area's (GTA) luxury housing market shifted into high gear in the final quarter of 2024, with sales over ...

“At our core, our people are our most important resource,” said UAB President Ray Watts. “We aspire every day to actively ...